The report shows that tariff policies could lead to a 12.9% increase in drug prices in the United States.

Local time on the 25th, a report commissioned by the American Pharmaceutical Trade Association showed that a 25% drug tariff would increase US drug costs by $51 billion annually, increase US production costs, and reduce the competitiveness of US drug exports. If all drug tariffs are passed on, US drug prices could rise by up to 12.9%.